Press release
Award-Winning Eczema App, ATOPIYO, Launches Text Posting Feature: Introducing "Tweet Piyo" - Beyond Visual Tracking to Strengthen Community Support for 31 Million Americans
CHIBA, Japan - August 21, 2025 - Eczema affects 31 million Americans, creating daily challenges that extend far beyond visible symptoms. ATOPIYO LLC, developer of Japan's largest eczema patient app, today announced the launch of "Tweet Piyo," a new short text-only posting feature that allows users to share thoughts, questions, and daily experiences without requiring photos. Additionally, the app introduces a blur function that gives users control over viewing sensitive images.Image: https://www.globalnewslines.com/uploads/2025/08/31dc6fa35aca0ded5c44141944d89a0f.jpg
Background: Meeting User Needs
Until now, ATOPIYO has been widely used for sharing and recording eczema-related photos to foster empathy and information exchange among patients. However, many users expressed a desire to also post quick notes such as "I just want to ask in words" or "I want to share my daily worries and findings without an image." The new text posting feature "Tweet Piyo" addresses this demand, making communication easier and more inclusive.
For image posts, a new function allows users to blur photos posted by others, such as severe cases, giving them control over what they view.
How It Works
Text Posting - Tap the pencil icon at the bottom of the app to write and share a text-only post.
Blur - Tap the eye icon in the lower right corner to toggle blurred or unblurred display of images.
About ATOPIYO
Image: https://www.globalnewslines.com/uploads/2025/08/cf30304e88cd2b3ce795d98bc908cd78.jpg
ATOPIYO is Japan's first anonymous image-sharing app specifically designed for eczema patients. Developed by former eczema patient Ryotaro Ako, the app enables users to anonymously record and share eczema-specific skin symptoms, itching experiences, and skincare routines to support early recovery.
Since launch, ATOPIYO has grown into Japan's largest eczema patient platform, with over 30,000 downloads and 67,000 uploaded images as of August 2025. It has won 12 national awards, including Japan's National Public Health Award. The app has also launched in the United States in June 2025.
ATOPIYO currently collaborates with 7 university hospitals and research institutions for big data analysis and pharmaceutical partnerships for disease awareness. Research utilizing ATOPIYO data was published in the prestigious international medical journal "Allergy" in May 2025, demonstrating its academic impact.
AppStore: https://apps.apple.com/app/id6475762535
GooglePlay: https://play.google.com/store/apps/details?id=com.atopiyo.atopiyous
Future Outlook
ATOPIYO will continue partnering with pharmaceutical companies and medical institutions to advance eczema research, product development, and disease awareness through digital innovation. The addition of text posting is the first of many planned feature expansions aimed at creating a more comprehensive and supportive platform for eczema patients.
"With 31 million Americans living with eczema, our mission goes beyond symptom tracking. The text posting feature reflects our commitment to meeting the evolving needs of our community." - Ryotaro Ako, Founder of ATOPIYO
Founder's Profile
Ryotaro Ako, a former eczema patient, is a programmer, holds a master's degree in engineering, and is a Certified Public Accountant. Having experienced three allergic conditions-eczema, asthma, and rhinitis-he engaged in volunteer work with patient associations. He developed ATOPIYO himself, drawing on feedback from eczema patients, insights from his wife Akiko Ako, a licensed pharmacist, and technical guidance from software engineers.
Major Awards
10th Health and Longevity Extension! Award - National Government Public Health Award
InnoVation 2020 Generation Award - National Government Innovation Award
Japan Healthcare Business Contest 2020 - National Government Excellence & Special Awards
Media Contact
Company Name: Atopiyo LLC
Contact Person: Ryotaro Ako
Email: Send Email [http://www.universalpressrelease.com/?pr=awardwinning-eczema-app-atopiyo-launches-text-posting-feature-introducing-tweet-piyo-beyond-visual-tracking-to-strengthen-community-support-for-31-million-americans]
City: Ichikawa
State: Chiba
Country: Japan
Website: https://www.atopiyo.com/en/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Award-Winning Eczema App, ATOPIYO, Launches Text Posting Feature: Introducing "Tweet Piyo" - Beyond Visual Tracking to Strengthen Community Support for 31 Million Americans here
News-ID: 4154596 • Views: …
More Releases from Getnews

Faith Through Fire How One Woman's Battle With a Rare Disease Became a Story of …
Diagnosed at just thirteen days old with a rare genetic disorder known as Maple Syrup Urine Disease (MSUD), Elizabeth Alison Stone was thrust into a world of uncertainty, strict medical regimens, and life-threatening challenges. In her new memoir, Pursuing God's Grace [https://www.amazon.com/Pursuing-Grace-Elizabeth-Alison-Stone/dp/B0F5JK8DB1/ref], Stone opens the door to her personal story of resilience, survival, and unshakable faith.
Image: https://www.globalnewslines.com/uploads/2025/10/9ddde09dd4e20f6f56a558e37b024a42.jpg
Through this deeply moving account, readers are invited to walk alongside Elizabeth as she…

Readers' Favorite recognizes "The Regression Strain" in its annual international …
Image: https://www.globalnewslines.com/uploads/2025/10/1759937772.jpg
Readers' Favorite recognizes "The Regression Strain" by Kevin Hwang in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0F9Q1L4KV.
The Readers' Favorite International Book Award Contest featured thousands of contestants from over a dozen countries, ranging from new independent authors to NYT best-sellers and celebrities.
Readers' Favorite is one of the largest book review and award contest sites on the Internet. They have earned the respect of renowned publishers like…

AquaShear Hydraulic Mixer: Breaking the Billion-Dollar Industrial Mixing Bottlen …
Image: https://www.globalnewslines.com/uploads/2025/10/8013919c55e3b21e0846e4550d226f1d.jpg
Across industries such as energy, water treatment, food processing, mining, and petrochemical refining, inefficient mixing has long been one of the most expensive bottlenecks. From delayed batches and wasted additives to clogged systems and costly downtime, the ripple effects of poor mixing add up to billions in annual losses for industrial operations. The newly relaunched AquaShear [http://aquashearusa.com?utm_source=release&utm_medium=press&utm_campaign=sept_2025] brand by Johnson Specialty Tools is stepping in with a patented approach…

Readers' Favorite recognizes "Pioneering Prosperity" in its annual international …
Image: https://www.globalnewslines.com/uploads/2025/10/1759937647.jpg
Readers' Favorite recognizes "Pioneering Prosperity" by Joyce Brand in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0D3HW2XRK. [http://www.amazon.com/gp/product/B0D3HW2XRK]
The Readers' Favorite International Book Award Contest featured thousands of contestants from over a dozen countries, ranging from new independent authors to NYT best-sellers and celebrities.
Image: https://m.media-amazon.com/images/I/41oWYhdMCvL._SL400_.jpg
Readers' Favorite is one of the largest book review and award contest sites on the Internet. They have earned the respect of renowned publishers…
More Releases for ATOPIYO
Atopic Dermatitis Market Overview 2025 and Growth US$ 31.68 Bn by 2033 | Japan I …
Atopic Dermatitis Market reached US$ 10.72 Billion in 2024 and is expected to reach US$ 31.68 Billion by 2033, growing at a CAGR of 13.7% during the forecast period 2025-2033.
Latest Japan‐Related News
Japan's top eczema app "Atopiyo" expands to the US - the app, developed in Japan, is now internationally available
Dupixent (dupilumab) receives approval in Japan for treating atopic dermatitis and other conditions
Maruho to co-develop topical biologic…